| 1 |
Comparison of IMPROVE and NIOSH Carbon Measurements
Judith C. Chow, John G. Watson, Dale Crow et al. · Aerosol Science and Technology
|
2001 |
887 |
| 2 |
Galectin-3: A Novel Mediator of Heart Failure Development and Progression
Rudolf A. de Boer, Adriaan A. Voors, Pieter Muntendam et al. · European Journal of Heart Failure
|
31 Jul 2009 |
527 |
| 3 |
Carotid Plaque Burden as a Measure of Subclinical Atherosclerosis
Henrik Hegaard Sillesen, Pieter Muntendam, Aram S. Adourian et al. · JACC. Cardiovascular imaging
Open access |
Jul 2012 |
279 |
| 4 |
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure
A. Rogier van der Velde, Lars Lysgaard Gullestad, Thor Ueland et al. · Circulation Heart Failure
|
9 Feb 2013 |
215 |
| 5 |
Rescuing drug discovery: in vivo systems pathology and systems pharmacology
J. van der Greef, Robert N McBurney · Nature Reviews Drug Discovery
Review |
Dec 2005 |
210 |
| 6 |
Metabolomics-Based Systems Biology and Personalized Medicine: Moving Towards n = 1 Clinical Trials?
J. van der Greef, Thomas Hankemeier, Robert N McBurney · Pharmacogenomics
|
Oct 2006 |
175 |
| 7 |
Baseline and Serial Measurements of Galectin-3 in Patients with Heart Failure: Relationship to Prognosis and Effect of Treatment with Valsartan in the Val-HeFT
Inder S. Anand, Thomas S. Rector, Michael A. Kuskowski et al. · European Journal of Heart Failure
|
5 Jan 2013 |
168 |
| 8 |
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials
Wouter C. Meijers, James Louis Januzzi, Christopher R. deFilippi et al. · American Heart Journal
Open access |
5 Mar 2014 |
158 |
| 9 |
Preclinical comparison of superpulse thulium fiber laser and a holmium:YAG laser for lithotripsy
Viktoria Andreeva, А З Винаров, Ilya V. Yaroslavsky et al. · World Journal of Urology
|
4 May 2019 |
157 |
| 10 |
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Lysgaard Gullestad, Thor Ueland, JOHN K. KJEKSHUS et al. · European Heart Journal
|
17 Apr 2012 |
156 |
| 11 |
The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease—study design and objectives
Pieter Muntendam, Carol J McCall, Javier Sanz et al. · American Heart Journal
|
Jul 2010 |
145 |
| 12 |
Multi-center determination of galectin-3 assay performance characteristics:
Robert H. Christenson, Show‐Hong Duh, Alan H.B. Wu et al. · Clinical Biochemistry
|
12 Feb 2010 |
144 |
| 13 |
Symbiosis of chemometrics and metabolomics: past, present, and future
J. van der Greef, Age K. Smilde · Journal of Chemometrics
Open access |
May 2005 |
137 |
| 14 |
Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology
Kaspar Broch, Thor Ueland, Ståle Haugset Nymo et al. · European Journal of Heart Failure
|
2 Feb 2012 |
133 |
| 15 |
Protein Biomarkers of New-Onset Cardiovascular Disease
Xiaoyan Yin, Subha Subramanian, Shih‐Jen Hwang et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
13 Feb 2014 |
108 |
| 16 |
Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique
Maria Paz Loscertales, Anna Roca, Pere Joan Ventura et al. · The Pediatric Infectious Disease Journal
|
Feb 2002 |
107 |
| 17 |
Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms
Yu Feng Guo, Armin Graber, Robert N McBurney et al. · BMC Bioinformatics
Open access |
3 Sep 2010 |
100 |
| 18 |
Lipidomic profiling identifies signatures of metabolic risk
Xiaoyan Yin, Christine M. Willinger, Joshua A. Keefe et al. · EBioMedicine
Open access |
23 Dec 2019 |
93 |
| 19 |
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Lysgaard Gullestad, Thor Ueland, JOHN K. KJEKSHUS et al. · American Heart Journal
|
29 Oct 2012 |
93 |
| 20 |
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Ana Oaknin et al. · Clinical Cancer Research
Open access |
26 Jun 2023 |
92 |
| 21 |
Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
Richard S. Finkel, Thomas O. Crawford, Kathryn J. Swoboda et al. · PLoS ONE
Open access |
27 Apr 2012 |
89 |
| 22 |
Galectin-3 in heart failure: high levels are associated with all-cause mortality
Thor Ueland, Pål Aukrust, Kaspar Broch et al. · International Journal of Cardiology
|
19 Jun 2011 |
83 |
| 23 |
Walkaway VSP using multimode optical fibers in a hybrid wireline
Gang Yu, Zhidong Cai, Yuanzhong Chen et al. · The Leading Edge
|
Jul 2016 |
80 |
| 24 |
Telehealth Weight Management Intervention for Adults with Physical Disabilities
James Howard Rimmer, Edward Wang, Christine A. Pellegrini et al. · American Journal of Physical Medicine & Rehabilitation
|
2 Oct 2013 |
80 |
| 25 |
Stromal Cell–Derived Factor 1 as a Biomarker of Heart Failure and Mortality Risk
Subha Subramanian, Chunyu Liu, Abraham Aviv et al. · Arteriosclerosis Thrombosis and Vascular Biology
Open access |
25 Jul 2014 |
80 |
| 26 |
Correlation network analysis for data integration and biomarker selection
Aram S. Adourian, Ezra G. Jennings, Raji Balasubramanian et al. · Molecular BioSystems
Open access |
16 Jan 2008 |
63 |
| 27 |
Critical Review of Prolotherapy for Osteoarthritis, Low Back Pain, and other Musculoskeletal Conditions
Sunny R. Kim, Todd P. Stitik, Patrick M. Foye et al. · American Journal of Physical Medicine & Rehabilitation
|
16 Apr 2004 |
62 |
| 28 |
Is b-type natriuretic peptide a useful screening test for systolic or diastolic dysfunction in patients with coronary disease? data from the heart and soul study
Kirsten B. Bibbins-Domingo, Maria N. Ansari, Nelson B. Schiller et al. · The American Journal of Medicine
Open access |
Apr 2004 |
60 |
| 29 |
The Liver Toxicity Biomarker Study: Phase I Design and Preliminary Results
Robert N McBurney et al. · Toxicologic Pathology
Open access |
2009 |
57 |
| 30 |
SMA-MAP: A Plasma Protein Panel for Spinal Muscular Atrophy
Dione T. Kobayashi et al. · PLoS ONE
Open access |
2 Apr 2013 |
53 |
| 31 |
Revealing structural modifications in thermomechanical reshaping of collagenous tissues using optical coherence elastography
Vladimir Y. Zaitsev, Alexander L. Matveyev, Lev A. Matveev et al. · Journal of Biophotonics
|
12 Nov 2018 |
52 |
| 32 |
A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran
Ulf Andersson, Johan Lindberg, Shunghuang Wang et al. · Biomarkers
|
Dec 2009 |
50 |
| 33 |
Comparative Study of [Three] LC−MALDI Workflows for the Analysis of Complex Proteomic Samples
Stephen J. Hattan, Jason Marchese, Nikita Khainovski et al. · Journal of Proteome Research
|
21 Oct 2005 |
45 |
| 34 |
Plasma Galectin-3 and Heart Failure Outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)
Craig Stolen, Aram S. Adourian, Timothy E. Meyer et al. · Journal of Cardiac Failure
Open access |
6 Aug 2014 |
42 |
| 35 |
Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis
Jinchun Sun, Linda S. Von Tungeln, Wade M. Hines et al. · Journal of Chromatography B
|
Jul 2009 |
38 |
| 36 |
Interplay of temperature, thermal‐stresses and strains in laser‐assisted modification of collagenous tissues: Speckle‐contrast and OCT‐based studies
Olga I. Baum, Vladimir Y. Zaitsev, Alexey V. Yuzhakov et al. · Journal of Biophotonics
|
Oct 2019 |
36 |
| 37 |
The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population
Erling Falk, Henrik Hegaard Sillesen, Pieter Muntendam et al. · Current Atherosclerosis Reports
Open access |
28 Jul 2011 |
36 |
| 38 |
Multivariate classification analysis of metabolomic data for candidate biomarker discovery in type 2 diabetes mellitus
Yang Qiu, Dilip Rajagopalan, Susan C. Connor et al. · Metabolomics
|
13 Aug 2008 |
33 |
| 39 |
The busy period of the migi1 vacation model with a bernoulli schedule
Ravi Ramaswamy, L. D. Servi · Stochastic Models
|
1988 |
33 |
| 40 |
Risk Factors for Near-Term Myocardial Infarction in Apparently Healthy Men and Women
Børge Grønne Nordestgaard, Aram S. Adourian, J Freiberg et al. · Clinical Chemistry
|
26 Feb 2010 |
32 |
| 41 |
Applications of a new subspace clustering algorithm (COSA) in medical systems biology
Doris Damian, Matej Orešič, Elwin R. Verheij et al. · Metabolomics
|
14 Feb 2007 |
30 |
| 42 |
Semi-Targeted Plasma Proteomics Discovery Workflow Utilizing Two-Stage Protein Depletion and Off-Line LC−MALDI MS/MS
Péter Juhász, Moira D. Lynch, Mahadevan Sethuraman et al. · Journal of Proteome Research
|
11 Oct 2010 |
29 |
| 43 |
Multiple imputation and analysis for high‐dimensional incomplete proteomics data
Xiaoyan Yin, Daniel Levy, Christine M. Willinger et al. · Statistics in Medicine
Open access |
12 Nov 2015 |
27 |
| 44 |
Proteomic Analysis in Type 2 Diabetes Patients before and after a Very Low Calorie Diet Reveals Potential Disease State and Intervention Specific Biomarkers
Maria A. Sleddering, Albert Jan Markvoort, Harish K. Dharuri et al. · PLoS ONE
Open access |
21 Nov 2014 |
26 |
| 45 |
Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes
Xiaoyan Yin, Subha Subramanian, Christine M. Willinger et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
23 Feb 2016 |
24 |
| 46 |
Ex vivo and animal study of the blue diode laser, Tm fiber laser, and their combination for laparoscopic partial nephrectomy
Valeriya Arkhipova, Mikhail E. Enikeev, Ekaterina Laukhtina et al. · Lasers in Surgery and Medicine
|
13 Sep 2019 |
22 |
| 47 |
Estimating the Numbers of Malaria Infections in Blood Samples Using High-Resolution Genotyping Data
Amanda J Ross, Cristian Koepfli, Xiaohong Li et al. · PLoS ONE
Open access |
29 Aug 2012 |
20 |
| 48 |
Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β
Oskar Hällgren, Johan A. Malmström, Lars Malmström et al. · Fibrogenesis & Tissue Repair
Open access |
28 Apr 2012 |
19 |
| 49 |
The Liver Toxicity Biomarker Study Phase I: Markers for the Effects of Tolcapone or Entacapone
Robert N McBurney et al. · Toxicologic Pathology
|
9 May 2012 |
19 |
| 50 |
Biomarker-Guided Therapies in Heart Failure: A Forum for Unified Strategies
Mona Fiuzat, Christopher M. O’Connor, François Gueyffier et al. · Journal of Cardiac Failure
Open access |
30 Jul 2013 |
18 |